药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rolitetracycline
Doconexent
The metabolism of Doconexent can be increased when combined with Dabrafenib.
Rolitetracycline
Quazepam
The metabolism of Quazepam can be increased when combined with Dabrafenib.
Rolitetracycline
Flunitrazepam
The metabolism of Flunitrazepam can be increased when combined with Dabrafenib.
Rolitetracycline
Terodiline
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Terodiline.
Rolitetracycline
Macimorelin
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Macimorelin.
Rolitetracycline
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Deutetrabenazine.
Rolitetracycline
Ivabradine
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Ivabradine.
Rolitetracycline
Iloperidone
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Iloperidone.
Rolitetracycline
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Tetrabenazine.
Rolitetracycline
Temafloxacin
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Temafloxacin.
Rolitetracycline
Lithium cation
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Lithium cation.
Rolitetracycline
Encorafenib
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Encorafenib.
Rolitetracycline
Dexverapamil
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Dexverapamil.
Rolitetracycline
Penfluridol
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Penfluridol.
Rolitetracycline
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Dexchlorpheniramine.
Rolitetracycline
Lorcainide
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Lorcainide.
Rolitetracycline
Bunaftine
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Bunaftine.
Rolitetracycline
Nizofenone
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Nizofenone.
Rolitetracycline
Otilonium
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Otilonium.
Rolitetracycline
Sultopride
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Sultopride.